Results
1 -
10 of
90
(Click
here to explore results)
- Exploring a structural protein–drug interactome for new therapeutics in lung cancer. Xiaodong Peng, Fang Wang, Liwei Li, Khuchtumur Bum-Erdene, David Xu, Bo Wang, Anthony A. Sinn, Karen E. Pollok, George E. Sandusky, Lang Li, John J. Turchi, Shadia I. Jalal, Samy O. Meroueh
, Mol. BioSyst.
, 2014
, 10
, 581
-
Approaches to pseudopeptidic ergopeptines. Part 3.1
Consequences of the incorporation of an
α-azaphenylalanine residue into the ergotamine
oxa-cyclolic system
. Anna Calcagni, Gino Lucente, Grazia Luisi, Francesco Pinnen, Domenico Rossi, Enrico Gavuzzo
, J. Chem. Soc., Perkin Trans. 1
, 1997
, 2223
- Resolution and quantification challenge of modern chemometric models in the determination of anti-migraine tablets containing ergotamine, caffeine, acetaminophen, and metoclopramide. Mahmoud M. Elkhoudary, Randa A. Abdel Salam, Ghada M. Hadad
, RSC Adv.
, 2017
, 7
, 20936
- Recent progress in ergot alkaloid research. Jing-Jing Chen, Meng-Yao Han, Ting Gong, Jin-Ling Yang, Ping Zhu
, RSC Adv.
, 2017
, 7
, 27384
- Ergot alkaloids: structure diversity, biosynthetic gene clusters and functional proof of biosynthetic genes. Christiane Wallwey, Shu-Ming Li
, Nat. Prod. Rep.
, 2011
, 28
, 496
- Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models. Claudio N. Cavasotto, Damián Palomba
, Chem. Commun.
, 2015
, 51
, 13576
- Biosynthesis of the ergot alkaloids. Dorota Jakubczyk, Johnathan Z. Cheng, Sarah E. O'Connor
, Nat. Prod. Rep.
, 2014
, 31
, 1328
- Outlining migrainous through dihydroergotamine–serotonin receptor interactions using quantum biochemistry. José X. Lima Neto, Vanessa P. Soares-Rachetti, Eudenilson L. Albuquerque, Vinicius Manzoni, Umberto L. Fulco
, New J. Chem.
, 2018
, 42
, 2401
- The alkaloids of ergot. George Barger
, Analyst
, 1937
, 62
, 340
- CLXXX.—The alkaloids of ergot. Part I. Sydney Smith, Geoffrey Millward Timmis
, J. Chem. Soc.
, 1930
, 1390